GLP1R and type 2 diabetes mellitus: Tirzepatide is a promising medication that activates both the glucose‐dependent insulinotropic polypeptide (GIP) and glucagon‐like peptide 1 (GLP‐1) receptors, revolutionising the treatment of T2DM as an adjunct to diet and exercise [11, 12].